[Health and economic benefits of mandatory regular vaccination in the Slovak Republic. II. Poliomyelitis].
The authors compared intervention strategy (vaccination) and non-intervention strategy (no vaccination). For the evaluation of health and financial effectiveness of regular polio vaccination the authors used the modelling of treatment of polio cases in 1957, and vaccination costs in 1996--the most recent year with available statistical data from the Slovak Republic. From these model years they calculated: the cost saving (11,919,106 Sk), cost-effectiveness ratio (79,944 Sk) and the net cost of vaccination (3,047,786 Sk). Simultaneously, they present a breakdown of cost-benefit analysis.
Hudecková
H
H
Odbor epidemiológie, Státny zdravotný ústav, Martin.
Straka
S
S
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D006801:Humans; D007223:Infant; D011051:Poliomyelitis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D018154:Slovakia / Q000453:epidemiology; D014611:Vaccination / Q000191:economics*